Reservoir Neuroscience is developing a platform aimed at an unaddressed mechanism in CNS disease, backed by real scientific conviction and a committed team.
The market has spent decades on getting molecules across the barrier. Reservoir asks a more fundamental question — what if the answer is to heal the barrier itself? That is a distinct, defensible, first-of-kind position.
A mechanism no one else is commercializing, in one of the largest unmet-need areas in medicine.
Founders with conviction, a clear thesis, and an early-stage development focus.
Discovery progress with a roadmap toward preclinical and clinical validation.
Because healing the barrier is a mechanism, not a single indication, the platform carries optionality across multiple CNS conditions — the kind of breadth serious investors in early-stage biotech look for.
We keep conversations with serious investors direct and straightforward.